Spina bifida before and after folic acid fortification in Canada

Philippe De Wals, Fassiatou Tairou, Margot I. Van Allen, R. Brian Lowry, Jane A. Evans, Michiel C. Van Den Hof, Marian Crowley, Soo Hong Uh, Pamela Zimmer, Barbara Sibbald, Bridget Fernandez, Nora S. Lee, Theophile Niyonsenga

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

BACKGROUND: In 1998, fortification of a large variety of cereal products with folic acid became mandatory in Canada. A multicentric study was carried out to assess the impact of this policy on the frequency of NTDs. The present analysis focused on spina bifida. METHODS: The study population included approximately 2 million livebirths, stillbirths, and terminations of pregnancies because of fetal anomalies among women residing in seven Canadian provinces, from 1993 to 2002. Spina bifida cases were divided according to the upper limit of the defect: upper (cranial, cervical, or thoracic) and lower (lumbar or sacral) defects. Based on published results of red blood cell folate tests, the study period was divided into prefortification, partial fortification, and full fortification periods. RESULTS: A total of 1,286 spina bifida cases were identified: 51% livebirths, 3% stillbirths, and 46% terminations. Prevalence decreased from 0.86/1,000 in the prefortification to 0.40 in the full fortification period, while the proportion of upper defects decreased from 32% to 13%. Following fortification, regional variations in the prevalence and distribution of sites almost disappeared. CONCLUSIONS: Results confirmed the etiologic heterogeneity of spina bifida and the more pronounced effect of folic acid in decreasing the risk of the more severe clinical presentations.

Original languageEnglish
Pages (from-to)622-626
Number of pages5
JournalBirth Defects Research Part A - Clinical and Molecular Teratology
Volume82
Issue number9
DOIs
Publication statusPublished - 1 Jan 2008
Externally publishedYes

Fingerprint

Spinal Dysraphism
Folic Acid
Canada
Stillbirth
Thorax
Erythrocytes
Pregnancy
Population

Cite this

De Wals, Philippe ; Tairou, Fassiatou ; Van Allen, Margot I. ; Lowry, R. Brian ; Evans, Jane A. ; Van Den Hof, Michiel C. ; Crowley, Marian ; Uh, Soo Hong ; Zimmer, Pamela ; Sibbald, Barbara ; Fernandez, Bridget ; Lee, Nora S. ; Niyonsenga, Theophile. / Spina bifida before and after folic acid fortification in Canada. In: Birth Defects Research Part A - Clinical and Molecular Teratology. 2008 ; Vol. 82, No. 9. pp. 622-626.
@article{570f1364f39f45148e53fe868021d7f2,
title = "Spina bifida before and after folic acid fortification in Canada",
abstract = "BACKGROUND: In 1998, fortification of a large variety of cereal products with folic acid became mandatory in Canada. A multicentric study was carried out to assess the impact of this policy on the frequency of NTDs. The present analysis focused on spina bifida. METHODS: The study population included approximately 2 million livebirths, stillbirths, and terminations of pregnancies because of fetal anomalies among women residing in seven Canadian provinces, from 1993 to 2002. Spina bifida cases were divided according to the upper limit of the defect: upper (cranial, cervical, or thoracic) and lower (lumbar or sacral) defects. Based on published results of red blood cell folate tests, the study period was divided into prefortification, partial fortification, and full fortification periods. RESULTS: A total of 1,286 spina bifida cases were identified: 51{\%} livebirths, 3{\%} stillbirths, and 46{\%} terminations. Prevalence decreased from 0.86/1,000 in the prefortification to 0.40 in the full fortification period, while the proportion of upper defects decreased from 32{\%} to 13{\%}. Following fortification, regional variations in the prevalence and distribution of sites almost disappeared. CONCLUSIONS: Results confirmed the etiologic heterogeneity of spina bifida and the more pronounced effect of folic acid in decreasing the risk of the more severe clinical presentations.",
keywords = "Folic acid, Food, Fortification, Neural tube defect, Program evaluation, Spina bifida",
author = "{De Wals}, Philippe and Fassiatou Tairou and {Van Allen}, {Margot I.} and Lowry, {R. Brian} and Evans, {Jane A.} and {Van Den Hof}, {Michiel C.} and Marian Crowley and Uh, {Soo Hong} and Pamela Zimmer and Barbara Sibbald and Bridget Fernandez and Lee, {Nora S.} and Theophile Niyonsenga",
year = "2008",
month = "1",
day = "1",
doi = "10.1002/bdra.20485",
language = "English",
volume = "82",
pages = "622--626",
journal = "Birth Defects Research Part A - Clinical and Molecular Teratology",
issn = "0040-3709",
publisher = "Wiley-Liss Inc.",
number = "9",

}

De Wals, P, Tairou, F, Van Allen, MI, Lowry, RB, Evans, JA, Van Den Hof, MC, Crowley, M, Uh, SH, Zimmer, P, Sibbald, B, Fernandez, B, Lee, NS & Niyonsenga, T 2008, 'Spina bifida before and after folic acid fortification in Canada', Birth Defects Research Part A - Clinical and Molecular Teratology, vol. 82, no. 9, pp. 622-626. https://doi.org/10.1002/bdra.20485

Spina bifida before and after folic acid fortification in Canada. / De Wals, Philippe; Tairou, Fassiatou; Van Allen, Margot I.; Lowry, R. Brian; Evans, Jane A.; Van Den Hof, Michiel C.; Crowley, Marian; Uh, Soo Hong; Zimmer, Pamela; Sibbald, Barbara; Fernandez, Bridget; Lee, Nora S.; Niyonsenga, Theophile.

In: Birth Defects Research Part A - Clinical and Molecular Teratology, Vol. 82, No. 9, 01.01.2008, p. 622-626.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Spina bifida before and after folic acid fortification in Canada

AU - De Wals, Philippe

AU - Tairou, Fassiatou

AU - Van Allen, Margot I.

AU - Lowry, R. Brian

AU - Evans, Jane A.

AU - Van Den Hof, Michiel C.

AU - Crowley, Marian

AU - Uh, Soo Hong

AU - Zimmer, Pamela

AU - Sibbald, Barbara

AU - Fernandez, Bridget

AU - Lee, Nora S.

AU - Niyonsenga, Theophile

PY - 2008/1/1

Y1 - 2008/1/1

N2 - BACKGROUND: In 1998, fortification of a large variety of cereal products with folic acid became mandatory in Canada. A multicentric study was carried out to assess the impact of this policy on the frequency of NTDs. The present analysis focused on spina bifida. METHODS: The study population included approximately 2 million livebirths, stillbirths, and terminations of pregnancies because of fetal anomalies among women residing in seven Canadian provinces, from 1993 to 2002. Spina bifida cases were divided according to the upper limit of the defect: upper (cranial, cervical, or thoracic) and lower (lumbar or sacral) defects. Based on published results of red blood cell folate tests, the study period was divided into prefortification, partial fortification, and full fortification periods. RESULTS: A total of 1,286 spina bifida cases were identified: 51% livebirths, 3% stillbirths, and 46% terminations. Prevalence decreased from 0.86/1,000 in the prefortification to 0.40 in the full fortification period, while the proportion of upper defects decreased from 32% to 13%. Following fortification, regional variations in the prevalence and distribution of sites almost disappeared. CONCLUSIONS: Results confirmed the etiologic heterogeneity of spina bifida and the more pronounced effect of folic acid in decreasing the risk of the more severe clinical presentations.

AB - BACKGROUND: In 1998, fortification of a large variety of cereal products with folic acid became mandatory in Canada. A multicentric study was carried out to assess the impact of this policy on the frequency of NTDs. The present analysis focused on spina bifida. METHODS: The study population included approximately 2 million livebirths, stillbirths, and terminations of pregnancies because of fetal anomalies among women residing in seven Canadian provinces, from 1993 to 2002. Spina bifida cases were divided according to the upper limit of the defect: upper (cranial, cervical, or thoracic) and lower (lumbar or sacral) defects. Based on published results of red blood cell folate tests, the study period was divided into prefortification, partial fortification, and full fortification periods. RESULTS: A total of 1,286 spina bifida cases were identified: 51% livebirths, 3% stillbirths, and 46% terminations. Prevalence decreased from 0.86/1,000 in the prefortification to 0.40 in the full fortification period, while the proportion of upper defects decreased from 32% to 13%. Following fortification, regional variations in the prevalence and distribution of sites almost disappeared. CONCLUSIONS: Results confirmed the etiologic heterogeneity of spina bifida and the more pronounced effect of folic acid in decreasing the risk of the more severe clinical presentations.

KW - Folic acid

KW - Food

KW - Fortification

KW - Neural tube defect

KW - Program evaluation

KW - Spina bifida

UR - http://www.scopus.com/inward/record.url?scp=52249123448&partnerID=8YFLogxK

U2 - 10.1002/bdra.20485

DO - 10.1002/bdra.20485

M3 - Article

VL - 82

SP - 622

EP - 626

JO - Birth Defects Research Part A - Clinical and Molecular Teratology

JF - Birth Defects Research Part A - Clinical and Molecular Teratology

SN - 0040-3709

IS - 9

ER -